The effect of monoamine oxidase inhibitors on the level of 5-hydroxyindoleacetic acid in human cerebrospinal fluid.
D002555:Cerebrospinal Fluid; D006801:Humans; D006897:Hydroxyindoleacetic Acid; D007210:Indoleacetic Acids; D007490:Iproniazid; D008996:Monoamine Oxidase Inhibitors; D009526:Nialamide
D007210:Indoleacetic Acids; D008996:Monoamine Oxidase Inhibitors; D006897:Hydroxyindoleacetic Acid; C030737:indoleacetic acid; D007490:Iproniazid; D009526:Nialamide
CEREBROSPINAL FLUID; INDOLACETIC ACID; IPRONIAZID; MONOAMINE OXIDASE INHIBITORS; NIALAMIDE